“…Starting with the HPV18 E6 C-terminal sequence, we designed a number of peptides to test specific peptide positions, including HPV16 E6, HPV18 E6, S RET T V, S RET D V, RRET T V, and RRET D V, where underlined residues differ from HPV18 E6. As a control, we also tested human SNX27, SHANK1, and GIPC PDZ targets previously studied, including GIRK3 (sequence: ESESKV), BPIX (WDETNL), GAIP (QSSSEA), TYRP1 (PNQSVV), and B1AR (ASESKV), as well as previously identified mbSHANK targets, including A9V7Z4 (EDETAL), A9UP44 (QSESRL), and A9UXE1 (QDETAL) [ 48 , 54 ]. Example competition experiment binding curves are in Figure 6 , and all K I binding affinity values are reported in Table 3 .…”